Becton, Dickinson and Company's Revenue by Segment
In fiscal year 2025, Becton, Dickinson and Company's revenue by segment (products & services) are as follows:
- Interventional: $5.22 B
- Life Sciences: $5.17 B
- Medical: $11.46 B
Learn more about Becton, Dickinson and Company’s Revenue by Geography
Check out competitors to Becton, Dickinson and Company in a side-by-side comparison.
Explore additional financial metrics for Becton, Dickinson and Company.
Becton, Dickinson and Company's Revenue Share by Segment
| Interventional | 4736000000 |
|---|---|
| Life Sciences | 5133000000 |
| Medical | 9502000000 |
| Interventional | 4980000000 |
|---|---|
| Life Sciences | 5191000000 |
| Medical | 10074000000 |
| Interventional | 5217000000 |
|---|---|
| Life Sciences | 5167000000 |
| Medical | 11456000000 |
The above chart shows Becton, Dickinson and Company's revenue percentage share by segment (products and services).
In fiscal year 2023, Becton, Dickinson and Company's revenue by segment is as follows:
- Interventional generated $4.74 B in revenue, representing 24.45% of its total revenue.
- Life Sciences generated $5.13 B in revenue, representing 26.5% of its total revenue.
- Medical generated $9.50 B in revenue, representing 49.05% of its total revenue.
The biggest segment for Becton, Dickinson and Company is the Medical, which represents 49.05% of its total revenue.
The smallest segment for Becton, Dickinson and Company is the Interventional, which represents 24.45% of its total revenue.
The above chart shows Becton, Dickinson and Company's revenue percentage share by segment (products and services).
In fiscal year 2024, Becton, Dickinson and Company's revenue by segment is as follows:
- Interventional generated $4.98 B in revenue, representing 24.6% of its total revenue.
- Life Sciences generated $5.19 B in revenue, representing 25.64% of its total revenue.
- Medical generated $10.07 B in revenue, representing 49.76% of its total revenue.
The biggest segment for Becton, Dickinson and Company is the Medical, which represents 49.76% of its total revenue.
The smallest segment for Becton, Dickinson and Company is the Interventional, which represents 24.6% of its total revenue.
The above chart shows Becton, Dickinson and Company's revenue percentage share by segment (products and services).
In fiscal year 2025, Becton, Dickinson and Company's revenue by segment is as follows:
- Interventional generated $5.22 B in revenue, representing 23.89% of its total revenue.
- Life Sciences generated $5.17 B in revenue, representing 23.66% of its total revenue.
- Medical generated $11.46 B in revenue, representing 52.45% of its total revenue.
The biggest segment for Becton, Dickinson and Company is the Medical, which represents 52.45% of its total revenue.
The smallest segment for Becton, Dickinson and Company is the Life Sciences, which represents 23.66% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Life Sciences | 26.5% | 25.64% | 23.66% |
| Medical | 49.05% | 49.76% | 52.45% |
| Interventional | 24.45% | 24.6% | 23.89% |
| Total Revenue | 100% | 100% | 100% |
Becton, Dickinson and Company's Segments Revenue Trend
The above chart shows the revenue trend of different segments of Becton, Dickinson and Company.
In fiscal year 2025, the Medical generated the most revenue ($11.46 B), and the Life Sciences generated the least revenue ($5.17 B).
Becton, Dickinson and Company's Revenue Growth Drivers
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
